Pharmaceuticals

Brawn Biotech Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 33 filings·Updated 15 Oct 2026
Showing 10 of 33 filings.
15 Oct 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) for the reporting quarter received from RCMC Registrar & Transfer Agent

Certificate details

  • Certificate under Regulation 74(5) for the reporting quarter received from RCMC, Registrar & Transfer Agent.
Filed 18:03View Source
29 Sept 20264 filings
Company UpdateGeneral

Brawn Biotech approves appointment of GDSM & Co as statutory auditors and director re-appointment

Auditor appointment

  • Appoints M/s GDSM and Co as statutory auditors, effective 29 Sep 2026, tenure to 2030-31.

Director re-appointment

  • Re-appoints Brij Raj Gupta as Director, liable to retire by rotation, DIN 00974969, shares 500,774.
Filed 15:46View Source
AGM/EGMAGM

Brawn Biotech 41st AGM approves financials, director re-appointment, statutory auditor appointment, and manager remuneration via VC/OAVM

AGM details

  • Date and time: 29 September 2026 at 11:00 A.M.
  • Mode: Video Conference/Other Audio-Visual Means (VC/OAVM)
  • Voting entitlement cut-off: 22 September 2026

Resolutions

  • Item 1: Adopt Audited financial statements for year ended 31 March 2026 (Ordinary).
  • Item 2: Re-appoint Brij Raj Gupta as Director (retires by rotation).
  • Item 3: Appoint M/s G D S M & Co as Statutory Auditors (Ordinary).
  • Item 4: Approve managerial remuneration for Amit Kumar (Manager-KMP).

Voting results by item

  • Item 1 passed; 1,001,478 in favour, 20 against.
  • Item 2 passed; 1,001,478 in favour, 20 against.
  • Item 3 passed; 1,001,478 in favour, 20 against.
  • Item 4 passed; 1,001,448 in favour, 50 against.

Directors and auditors

  • Director changes: Brij Raj Gupta retires by rotation and seeks re-appointment.
  • Auditors: M/s G D S M & Co appointed as Statutory Auditors.

Remuneration approvals

  • Remuneration approved for Manager-KMP Amit Kumar as per Companies Act.
Filed 15:35View Source
AGM/EGMAGM

Brawn Biotech's 41st AGM held via VC/OAVM on 29 Sep 2026; four resolutions voted.

AGM Details & Proceedings

  • 41st AGM held 29 Sep 2026 at 11:00 AM via VC/OAVM.
  • Quorum of 44 members present through VC/OAVM.
  • Four resolutions forming part of the notice were put to vote.
  • Adoption of Audited Financial Statements and Directors’ Report discussed; no qualifications in audit report.
  • Remote e-voting from 26 Sep 2026 9:00 AM to 28 Sep 2026 5:00 PM; on-site voting at AGM.
  • Scrutinizer appointed to conduct the voting process.
Filed 12:58View Source
AGM/EGMAGM

AGM filing excerpt for Brawn Biotech Ltd contains no extractable governance or financial details

  • No material AGM details disclosed in this excerpt.
Filed 12:53View Source
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Brawn Biotech Ltd – Closure of Trading Window

Brawn Biotech Ltd – Closure of Trading Window

Filed 10:23View Source
2 Sept 20262 filings
Company UpdateGeneral

Brawn Biotech issues letters to unregistered-email shareholders for 41st AGM notice access

Unregistered-email shareholders

  • Sep 2, 2026: letters issued to shareholders without registered emails to access 41st AGM Notice.
Filed 16:46View Source
Company UpdateNewspaper Publication

Newspaper Publication for 41st Notice of AGM.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 12:17View Source
14 Aug 20261 filing
Company UpdateNewspaper Publication

Publication of Un-audited financial results for the quarter ended June 30, 2026.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:39View Source
13 Aug 20261 filing
ResultFinancial Results

Brawn Biotech approves unaudited Q1 June 30, 2026 results; appoints auditors; fixes AGM date.

Financial results

  • Board approved standalone unaudited quarterly results for quarter ended 30 June 2026.
  • Limited Review Report accompanying the results was approved.
  • Board meeting held on 13 August 2026.

Auditors

  • Recommend appointment of M/s GD S M and Co as statutory auditors for five years.
  • Term from AGM 2026-27 to AGM 2030-31, subject to shareholder approval.

AGM & notices

  • 41st AGM via VC/OAVM on Sep 29, 2026.
  • Draft AGM notice to shareholders.

Board report & CFO certificate

  • Board approved the Board Report for year ended March 31, 2026.
  • CFO certificate under Reg 33(2)(a) confirms unaudited results as true and fair.
Filed 13:17View Source
Showing 10 of 33 filings